Variant that contains the cell's AGR2 widespread term eventually cholangiocarcinoma (M213L5) Cholangiocarcinoma cells greater than the initial phases (M213L0) is a variant F.
AGR2 variant is expressed in cells of cholangiocarcinoma metastatic progression (M213L5) over cell cholangiocarcinoma early stage (M213L0) is a variant F.
Variant with AGR2 expression in cholangiocarcinoma cells phase spread spread (M213L5). More cholangiocarcinoma cells during the initial stage (stage M213L0) was variant F.